Egyptian Medical Mission Delivers Critical Care to Hajj Pilgrims
Egyptian clinics are operating 24/7 in Makkah and Madinah, offering care to both Egyptian and non-Egyptian pilgrims alike.
May 28, 2025
The Egyptian medical mission for Hajj announced that it has handled several critical medical cases among pilgrims visiting its clinics at hotels and other key points across Makkah and Madinah, including patients requiring kidney dialysis and chemotherapy. One individual was transferred for dialysis treatment, while another was referred for a chemotherapy session. These interventions fall under a comprehensive medical framework designed to provide urgent and specialized care to Egyptian pilgrims during the Hajj season.
The mission confirmed that full coordination is ongoing with Saudi hospitals to maintain a high standard of medical service. Transferred patients are being monitored on a daily basis to ensure their health remains stable, allowing them to safely continue their pilgrimage.
Pilgrims have been advised to adhere to all health guidelines and to seek immediate medical attention at the clinics should they experience any symptoms. The clinics remain open around the clock and offer services to both Egyptian and non-Egyptian pilgrims without discrimination.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mada
10 hours ago
- Mada
Laila Soueif hospitalized amid hunger strike for her son's release
Laila Soueif was admitted to St. Thomas's Hospital in central London on Thursday night as her health deteriorated due to the hunger strike she has been on for over 200 days to call for her son's release from prison. Activist and writer Alaa Abd El Fattah has been in prison since 2019, in what United Nations experts ruled earlier this week is arbitrary detention by Egyptian authorities. Soueif began a hunger strike in 2024, when Abd El Fattah's prison sentence on false news charges was due to come to an end but prosecutors refused petitions to credit the two years he served in remand detention toward his final sentence. Soueif has appealed to authorities in both Egypt and the United Kingdom, where she and her family hold second nationality. But 'nothing has changed,' Soueif said in a statement 10 days ago, announcing that she would resume the full hunger strike. At medics' advice, the assistant mathematics professor at Cairo University had lessened the restrictions on her caloric intake while maintaining a partial hunger strike in recent months following an initial hospital admission in February. In a statement on Thursday evening, her family said Soueif's blood sugar had dropped to dangerous levels. Sharing an image captured at the hospital, Soueif's daughter, Mona Seif, noted that until this afternoon, Soueif was still conscious but had declined medical intervention. British Prime Minister Keir Starmer last contacted President Abdel Fattah al-Sisi on May 22 to push for Abd El Fattah's release. Though Soueif acknowledged Starmer's intentions in her announcement that she would resume a full hunger strike, she concluded that 'nothing is happening' to release her son, adding, 'we have used up more days than we ever thought we had. We need Alaa released now.'
Egypt Today
17 hours ago
- Egypt Today
Preventive health services provided to more than 50K Egyptian pilgrims: Ministry
A doctor gives preventive health advice to a group of Egyptian female pilgrims at an airport before heading to Saudi Arabia on May 30, 2025- press photo CAIRO – 30 May 2025: Egypt's Ministry of Health and Population announced it has provided preventive health services to a total of 50,598 Egyptian pilgrims and the distribution of 20,556 various medical and preventive supplies to those traveling to the Holy Lands of Mecca in the Kingdom of Saudi Arabia for the Hajj season of 1446 AH / 2025 AD. These services were delivered through Egypt's international airports—Cairo, Luxor, Aswan, and Sohag—as well as the ports of Nuweiba, Safaga, and Hurghada, during the period from May 14 to May 25, 2025. This initiative is part of the Ministry's broader preventive strategy, implemented through quarantine health stations designated for Egyptian pilgrims. It underscores the Ministry's ongoing commitment to safeguarding the health and well-being of all pilgrims throughout their journey—from departure to the completion of Hajj rituals and their safe return home. Hossam Abdel Ghaffar, the official spokesperson for the Ministry of Health and Population, affirmed the Ministry's dedication to delivering high-quality preventive healthcare services to the pilgrims. He noted that health conditions of pilgrims are being monitored around the clock, in coordination with all relevant authorities, to ensure a safe and spiritually fulfilling Hajj experience. Abdel Ghaffar also reported that preventive education and health awareness sessions related to Hajj rituals and personal health were provided to 234 pilgrims. Additionally, 298 individuals visited quarantine clinics at designated health stations, where they received the necessary medical consultations and services to ensure their safety. The Ministry reiterated its readiness to support all pilgrims and its continued efforts to provide integrated healthcare throughout the Hajj season.
Daily News Egypt
2 days ago
- Daily News Egypt
Egypt, US partner to launch global pharmaceutical manufacturing, export venture
Egypt has signed a major joint venture agreement with US-based Dawah Pharma to manufacture and export pharmaceutical products and nutritional supplements to global markets, with a strategic focus on North America and Europe. The deal marks a significant milestone in Egypt's push to expand its pharmaceutical exports and attract foreign investment to its health sector. Prime Minister Mostafa Madbouly witnessed the signing ceremony, which took place in the presence of Deputy Prime Minister for Human Development and Minister of Health and Population Khaled Abdel Ghaffar, Minister of Public Enterprise Sector Mohamed El-Shimy, Head of the Egyptian Drug Authority Ali El-Ghamrawy, and Hisham Setit, Head of the Unified Procurement Authority for Medical Supplies and Technology. The agreement was signed by Ashraf El-Khouly, Executive Managing Director of the Egyptian Holding Company for Pharmaceuticals—affiliated with the Ministry of Public Enterprise Sector—and Hossam Abdel Maksoud, Chairman of Dawah Pharma. Prime Minister Madbouly said the agreement reflects Egypt's broader strategy to enhance national industries, with the pharmaceutical sector identified as a key priority. He described the partnership as a strong vote of confidence in the quality and potential of Egyptian manufacturing, particularly in the medical field. Minister El-Shimy emphasized that the partnership follows major investments to modernize the holding company's infrastructure, upgrade production lines, and align operations with international Good Manufacturing Practices (GMP). He described the venture as a pivotal step in Egypt's plan to boost pharmaceutical exports, strengthen international collaboration, and increase foreign direct investment. Under the agreement, the new joint venture will manufacture and export a wide range of products including ampoules, nutritional supplements, sterile injections, ophthalmic preparations, and over-the-counter (OTC) medications. The first phase will focus on exporting six pre-approved dietary supplements to the US market—an unprecedented move for the Holding Company for Pharmaceuticals, after meeting all relevant international regulatory and quality benchmarks. The venture will leverage state-of-the-art manufacturing technologies for a diverse range of dosage forms including syrups, tablets, ampoules, pre-filled syringes, and transdermal patches. This is expected to accelerate global market entry for Egyptian-made products and support long-term growth for the company and its subsidiaries. El-Shimy affirmed that the new company will comply with the most stringent international regulations, particularly those set by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to ensure the competitiveness of Egyptian products in North America, Europe, and emerging markets in Africa and Asia. As per the terms of the agreement, the Egyptian Holding Company for Pharmaceuticals will hold a 40% stake in the joint venture, while Dawah Pharma will own 60%. The partnership will also spearhead efforts to open new international markets for Egyptian pharmaceutical exports, solidifying Egypt's position as a regional hub for high-quality medical manufacturing.
